Apollo Ventures is a venture capital firm in Germany that focuses on assets that treat, prevent, or even reverse age-related diseases such as alzheimer's, heart disease, sarcopenia, frailty, and cancer, with the goal of increasing healthy human lifespan. Founded 2016 in Hamburg, Germany by James Peyer, Nils Regge and Ole Mensching, and this venture capital firm invests in early stage ventures and seed. Its portfolio companies include Aeovian Pharmaceuticals, Samsara Therapeutics and Cleara Biotech. As of February 2020, Apollo Ventures has made four investments. Their most recent investment was on October 3, 2019, when Aeovian Pharmaceuticals raised $37M.
Timeline
Funded Companies
People
Dr. Steven Leunert
CFO
Dr. Victor Pavlenko
Venture Developer
James Peyer
Co-founder
James Peyer, PhD
Founder
Jens Eckstein, PhD
Managing Partner
Nils Regge
Co-Founder & Managing Director
Ole Mensching, PhD
Co-Founder & Head of HR
Victor Bustos, PhD
Venture Analyst
Further reading
This Scientist-Turned-VC Wants to Extend Life - NEO.LIFE - Medium
Karen Weintraub
Web
Documentaries, videos and podcasts
Companies
Aeovian Pharmaceuticals
Cleara Biotech
Samsara Therapeutics